B

Jan 08 2026HEALTH

The Ozempic Dilemma: Why Stopping Too Soon Can Backfire

Obesity drugs like Ozempic and Wegovy are game-changers. They help people shed pounds faster than diet and exercise alone. But quitting these meds can lead to quick weight regain. Research from the University of Oxford found that people who stop GLP-1 drugs often gain back almost a pound every month

reading time less than a minute
Jan 08 2026ENVIRONMENT

Simple Swaps for a Greener You

Living greener doesn't have to be hard. Small changes in daily habits can make a big difference. Here are some easy swaps to help you cut down on waste and live more sustainably. Start with the kitchen. Edible cutlery is a fun way to skip plastic. These utensils are made to be eaten, so they won't

reading time less than a minute
Jan 08 2026SPORTS

Brock Purdy: From Underdog to Superstar with a Heart of Gold

Brock Purdy's journey from being the last pick in the NFL Draft to a key player in the San Francisco 49ers is nothing short of inspiring. It's been quite a ride for him. Just a few years ago, he was sharing a place with roommates and working hard to keep his spot on the team. Now, he's aiming for hi

reading time less than a minute
Jan 08 2026HEALTH

Bugs with a Bite: Chagas Disease on the Rise Near the Border

In the Southwest, a tiny bug is causing big worries. These bugs, called kissing bugs, are spreading a disease called Chagas. Scientists found that almost 9 out of 10 of these bugs carry the parasite that causes Chagas. Chagas disease is sneaky. It might not show any signs for years. But over time,

reading time less than a minute
Jan 08 2026HEALTH

Making Sense of Takeaway Choices: Calories and Beyond

Takeaway foods are often seen as quick and tasty, but they can be heavy on calories and light on nutrition. In April 2022, England made a big move by requiring large takeaway chains to show calorie counts on their menus. The goal? To help people make healthier choices. But does this really work? And

reading time less than a minute
Jan 08 2026BUSINESS

A New Era for MannKind: What's Next in 2026?

MannKind, a company focused on treating long-term illnesses, had a strong finish to 2025. They acquired another company, scPharmaceuticals, and made over $100 million in their last quarter. This success has set the stage for an exciting 2026, with two major products potentially hitting the market.

reading time less than a minute
Jan 08 2026POLITICS

Novato's Mayor Leaves Office with a Year of Wins and Tough Lessons

Novato's former Mayor, Tim O’Connor, wrapped up his term in December, looking back at a year packed with achievements and challenges. He pointed out that the city made big strides in 2025, like catching up on audits, giving out over $1 million for affordable housing, and starting a grant program to

reading time less than a minute
Jan 08 2026SCIENCE

Smart Particles Fight Rust on Aluminum

Scientists have developed a clever way to protect aluminum from rust. They used tiny particles called layered double hydroxides (LDHs) to hold a special chemical called sebacate (SB). These particles release SB only when needed, like a smart defense system. First, they created these particles and s

reading time less than a minute
Jan 08 2026HEALTH

Vaccine Choices: Why the CDC's New Approach is a Good Thing

The CDC has updated its vaccine schedule for kids. This change is not about being anti-science. It is about giving parents more choices. Before, parents who asked questions were often treated badly. They were called anti-science or told they were putting other kids at risk. Now, the CDC is saying th

reading time less than a minute
Jan 08 2026SCIENCE

New York's Science Future: Invest or Fall Behind

New York has long been a big deal in the world of science. It's the second biggest recipient of National Institutes of Health money. Plus, it has more top-notch academic institutions doing research than any other state. The state trains a lot of doctors and biomedical researchers. But this leadershi

reading time less than a minute